CE Information

This activity is jointly provided by the Consortium of Multiple Sclerosis Centers (CMSC), the International Organization of Multiple Sclerosis Nurses (IOMSN), and Catamount Medical Education.

This activity is supported by educational grants from Keenova Therapeutics, previously Mallinckrodt Pharmaceuticals, Novartis, and TG Therapeutics.

Release Date
March 19, 2026

Expiration Date
March 19, 2027

Target Audience
This activity is intended for nurses who care for people living with multiple sclerosis (MS).

Agenda
Welcoming Remarks

Memorial Lecture - The Nurse’s Role in Comprehensive Care
Colleen Harris, MN, NP, MSCN (Program Chair)

Diagnosis: Updates and Approaches to Supporting and Educating Patients
Amy Perrin Ross, APN, CNRN, MSCN

Choices and Challenges in MS Treatment
Amber Peskin, APRN, CNS, MSCN

Recognizing and Managing Visible Symptoms of MS
Jeffrey Hernandez, DNP, APRN-C, MSCN

Shedding Light on Invisible Symptoms of MS
Jeffrey Hernandez, DNP, APRN-C, MSCN

Supporting Rehabilitation: Educating and Encouraging Patients
Patricia Bobryk, MHS, PT, MSCS, ATP

Panel Discussion - Factors Contributing to Disparities in MS Care and Outcomes

Learning Objectives
Upon completion of this activity, participants should be able to:

• Recognize the importance of comprehensive care in MS management and the nurse’s role in optimizing patient outcomes
• Discuss strategies for early diagnosis of MS and approaches to educating patients about both the disease and the diagnostic process
• Review information on current and emerging therapies and their relevance to the development of individualized management strategies for patients with MS
• Describe strategies to address common MS symptoms (primary, secondary, tertiary) and the nurse’s role in assisting patients in implementing these strategies and evaluating patient response
• Review invisible symptoms of MS and strategies to recognize, assess and manage these in individual patients
• Identify rehabilitation modalities and the nurse’s role in supporting the integration of rehabilitation therapy in the management and care of patients living with MS
• Discuss common factors that affect disparities in MS care and the nurse’s role in mitigating modifiable barriers
• Apply nursing interventions that support and promote best practices for interprofessional team-based care of patients with MS

Faculty
Colleen Harris, MN, NP, MSCN (Program Chair)
MS Clinic Nurse Practitioner
University of Calgary MS Clinic
Alberta, Canada

Patricia Bobryk, MHS, PT, MSCS, ATP
University of Colorado Health
Yampa Valley Medical Center
Steamboat Springs, Colorado

Jeffrey Hernandez, DNP, APRN-C, MSCN
Supervisor, Advanced Practice Providers, Multiple Sclerosis Center of Excellence
Department of Neurology, UHealth – University of Miami Health System
Affiliated Assistant Professor of Clinical, School of Nursing & Health Studies
University of Miami
Miami, Florida

Amy Perrin Ross, APN, CNRN, MSCN
Neuroscience Consultant
Chicago, Illinois

Amber Peskin, APRN, CNS, MSCN
The Desi Roth Harrison Multiple Sclerosis Center at Ochsner
New Orleans, Louisiana

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by The Consortium of Multiple Sclerosis Centers (CMSC), the International Organization of Multiple Sclerosis Nurses (IOMSN), and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

Credit Designation

Nurses
The CMSC designates this activity for a maximum of 5.0 nursing continuing professional development (NCPD) credits (2.0 in the area of pharmacology).

All other health care professionals completing this course will be issued a statement of participation.

Request for Credit
Upon completion of the evaluation, your certificate will be emailed to you.

How to Participate in This Activity and Obtain CE Credit
There are no fees for participating and receiving credit for this activity. During the period that the activity is available for credit, participants must:
1) Read the CE information
2) Complete the pretest
3) View the content
4) Complete the posttest and the evaluation form

A score of 67% (4 out of 6 correct answers) must be achieved on the posttest to successfully complete the activity. If you do not receive a passing score, you will receive a message notifying you that you did not pass the posttest. You may retake the posttest until successful. Upon completion of the evaluation, your certificate will be emailed to you.

Disclosures of Financial Relationships
In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Continuing Education, CMSC, IOMSN, and Catamount Medical Education require that individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies. CMSC, IOMSN, Catamount Medical Education mitigate all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, CMSC, IOMSN, Catamount Medical Education seek to verify that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. CMSC, IOMSN, and Catamount Medical Education are committed to providing learners with high-quality CE activities that promote improvements in health care and not those of a commercial interest.

Faculty Disclosures
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Colleen Harris, MN, NP, MSCN
Consulting: Biogen Inc.; EMD Serono, Inc.; F. Hoffmann-La Roche Ltd; Novartis Pharmaceuticals Corporation; Sanofi.

Patricia Bobryk, MHS, PT, MSCS, ATP
No relevant financial relationships to disclose.

Jeffrey Hernandez, DNP, APRN-C, MSCN
Consulting/Advisor/Speaker Fees: Amgen Inc.; Banner Life Sciences LLC; EMD Serono, Inc.; Genentech, Inc.; Novartis Pharmaceuticals Corporation; Sanofi; TG Therapeutics, Inc.

Amy Perrin Ross, APN, CNRN, MSCN
Consulting: Alexion Pharmaceuticals, Inc.; Amgen Inc.; Bristol Myers Squibb Company; EMD Serono, Inc.; F. Hoffmann-La Roche Ltd; UCB, Inc.; Viatris Inc.

Amber Peskin, APRN, CNS, MSCN
No relevant financial relationships to disclose.

Activity Staff Disclosures
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Kathleen Costello, CRNP, MSCN, and Laurie Scudder, DNP, NP, served as planners and reviewers and have disclosed no relevant financial relationships.

All other planners, reviewers, staff, or other members of the Continuing Professional Education Committee at CMSC who control content have disclosed no relevant financial relationships.

The planners, reviewers, staff, or other members of the Continuing Professional Education Committee at the IOMSN who control content have disclosed no relevant financial relationships.

The planners, reviewers, editors, staff, CE committee, or other members at Catamount Medical Education who control content have disclosed no relevant financial relationships.

Our Policy on Privacy
CMSC, IOMSN, and Catamount Medical Education, LLC, respect your privacy. All personal information that is provided to Catamount Medical Education, LLC, is protected and will not be sold to a third party for commercial purposes. All personally identifiable information contained in the Catamount Medical Education, LLC, registration databases is treated as confidential and will be used only for the purposes stated in this policy, except where required by law. Catamount Medical Education, LLC, maintains user databases that contain mailing and user profile information as well as a record of the CE activities viewed and the posttest and evaluation results for CE credit. This information is provided to activity collaborators for the purposes of CE recordkeeping. By participating in this activity, you agree that Catamount Medical Education, LLC, has full permission to provide this information.

Catamount Medical Education, LLC, safeguards against the loss, misuse, or alteration of information that we have collected in this activity.

Disclosure of Unlabeled Use
CMSC, IOMSN, and Catamount Medical Education require CE faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information
For questions about this activity, please contact Catamount Medical Education at info@catmeded.com.